Vera Therapeutics Inc (VERA)
37.98
+1.03
(+2.79%)
USD |
NASDAQ |
May 31, 16:00
Vera Therapeutics Cash and Short Term Investments (Quarterly): 403.66M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 403.66M |
| December 31, 2023 | 160.72M |
| September 30, 2023 | 159.94M |
| June 30, 2023 | 181.02M |
| March 31, 2023 | 197.15M |
| December 31, 2022 | 114.65M |
| September 30, 2022 | 114.42M |
| Date | Value |
|---|---|
| June 30, 2022 | 131.93M |
| March 31, 2022 | 150.94M |
| December 31, 2021 | 79.67M |
| September 30, 2021 | 86.19M |
| June 30, 2021 | 91.62M |
| March 31, 2021 | 49.50M |
| December 31, 2020 | 53.65M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
49.50M
Minimum
Mar 2021
403.66M
Maximum
Mar 2024
141.08M
Average
123.29M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 10.17B |
| Alpine Immune Sciences Inc (DELISTED) | 305.66M |
| Fate Therapeutics Inc | 383.54M |
| Mersana Therapeutics Inc | 183.15M |
| Equillium Inc | 32.28M |